ProQR Therapeutics NV (PRQR)
1.40
-0.07
(-4.76%)
USD |
NASDAQ |
Jun 10, 14:39
ProQR Therapeutics Enterprise Value : 77.22M for June 9, 2026
Enterprise Value Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Enterprise Value Benchmarks
| Pharming Group NV | 828.37M |
| NewAmsterdam Pharma Co. NV | 2.906B |
| Kamada Ltd. | 356.14M |
| Syndax Pharmaceuticals, Inc. | 1.560B |
| Opus Genetics, Inc. | 257.30M |
Enterprise Value Related Metrics
| Net Income (Quarterly) | -15.66M |
| Revenue (Quarterly) | 2.378M |
| Total Expenses (Quarterly) | 18.04M |
| EPS Diluted (Quarterly) | -0.1486 |
| Gross Profit Margin (Quarterly) | 65.86% |
| Profit Margin (Quarterly) | -658.3% |
| Earnings Yield | -35.89% |
| Normalized Earnings Yield | -35.90 |